MedTrace Logo

Measuring Response to Depression Treatment

NCT00924183 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2011-03-23

No results posted yet for this study

Summary

The primary goal of this study is to compare a new symptoms rating questionnaire, called the Vancouver Semi-Structured Interview for Depression (V-SID), to the traditionally used questionnaires. The investigators predict that the V-SID will be more sensitive to patients' improvement than are traditional questionnaires.

Conditions

Interventions

OTHER

Treatment-as-usual

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.

    lead OTHER

Principal Investigators

  • Diane McIntosh, MD, FRCPC · Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00924183 on ClinicalTrials.gov